title: Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study.
authors.forename: G
authors.initials: G
authors.lastname: Gardin
authors.forename: C
authors.initials: C
authors.lastname: Barone
authors.forename: O
authors.initials: O
authors.lastname: Nascimben
authors.forename: G
authors.initials: G
authors.lastname: Ianniello
authors.forename: F
authors.initials: F
authors.lastname: Sturba
authors.forename: A
authors.initials: A
authors.lastname: Contu
authors.forename: P
authors.initials: P
authors.lastname: Pronzato
authors.forename: R
authors.initials: R
authors.lastname: Rosso
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007191:Indazoles / Q000008:administration & dosage; D008875:Middle Aged
chemical_list: D007191:Indazoles; D015251:Epirubicin; D003520:Cyclophosphamide; C016371:lonidamine